Skip to main content
. 2019 Jan 11;9:1888. doi: 10.3389/fphys.2018.01888

Figure 5.

Figure 5

Effects of class I drugs on human atrial electrophysiology in SQT1. Effects of (A) disopyramide (DISO), (B) quinidine (QUIN), and (C) propafenone (PROPAF) on (i) single human atrial cell action potentials (APs) under wild type (WT) conditions (blue, dashed line), drug-free WT-N588K (SQT1) conditions (green, solid line), and SQT1 + varying drug concentrations (purple, orange, and red solid lines). Corresponding fractional block of (ii) IKr and (iii) INa, and (iv) increase in APD90 (red) and effective refractory period (ERP; blue). (D) Activation sequences in the 3D anatomical human atria model under (i) drug-free SQT1 (control – C), (ii) SQT1 + 2 μM DISO, (iii) SQT1 + 2 μM QUIN, and (iv) SQT1 + 0.5 μM PROPAF conditions, with corresponding (E) activation (ACT) time summarized as a barchart. All simulations performed at a basic cycle length of 1,000 ms.